Abstract:
Medicinal plant products are common medication therapy in traditional healing 
practices. However, the product plant species and their health value are often not 
scientifically authenticated. Given multiple challenges of unmet needs in care and 
management of HIV conditions, People living with HIV (PLWHIV) are prone to 
utilization of the plants with consequent risk of lack of expected benefits and at worst, 
fatality. The aim of this study was to identify plants used by PLWHIV in Hamuyundi
and Mukhwa communities in Western Kenya and to determine cytotoxicity, anti-Herpes 
activity, antioxidant value and to phytochemical groups of selected plant species. The 
identification of plants was carried out by qualitative ethnobotanical survey, using 
Community Health Workers as key informants. Plant species were collected from the 
field and botanically identified at the University of Nairobi herbarium. By literature 
search, secondary metabolites and pharmacological activity reported in previous studies
on the plants were identified. Water extract of eight selected medicinal plants were
tested for cytotoxicity and anti-herpes activity using Vero cell and Herpes simplex type 
1 (HSV-1). The effect of extract on cell metabolism of tetrazolium dye (MTT) was 
measured to determine cytotoxicity. The anti-herpes activity was determined by 
measuring metabolism of MTT by cells exposed to HSV-1 in presence of extracts. The 
antioxidant value was determined by measuring reduction of 2, 2-Diphenyl-1-
picrylhydrazyl (DPPH) by extracts of selected plant species. The extracts were then 
tested for the presence of flavonoids, terpenoids, alkaloids, saponins and phenols
qualitative procedures. At Hamuyundi community, a total of 36 plant species from 26 
families were identified while in Mukhwa, 29 species distributed in 17 families were 
identified. From literature, it was established that a third of plant species identified as 
medicinal in both Hamuyundi and Mukhwa have some of their pharmaceutical activity
and or phytochemical contents identified. Except for Garcinia buchananii (Baker)
(Bark) and Croton macrostachys (Hoechst) (Bark) that gave maximum nontoxic
concentration (MNC) of 40 µg/mL each, all the other species; Tithonia diversifolia 
(Hemsl.) Gray (Roots), Schkuria piñata (Lam) O.Ktze (Leaves), Entada abyssinica (A. 
Rich) (bark), Vernonia adoensis Walp (roots), Plumeria alba L. (leaves), Caesalpinia 
decapetala (Roth. I. Alston) (root) gave MNC of 20 µg/mL and below. The extract 
concentration that was cytotoxic to 50% of the cells (CC50) of A. abyssinica, G. 
buchananii and C. macrostachys were above 500µg/mL while CC50 of C. decapetala
(roots), V. adoensis (roots) T. diversifolia (roots), P. alba (leaves) and S. pinata (leaves) 
were 500, 470, 460, 120 and 90 µg/mL respectively. The best anti-herpes activity was 
obtained from G. buchanii (stem bark), giving an extract concentration inhibiting 50% 
of virus activity (IC50) at 20µg/mL) and C. decapetala (whole root) giving IC50 at 
80µg/mL. Therapeutic index (TI) of G. buchanii was ˃ 25 and that of C. decapetala was
˃ 6. Garcinia buchananii extract was active against HSV-1 infection in mice at 
500µg/mL, when compared with negative control by independent t-test, significantly 
delaying onset of symptoms (p = 0.006), progression of symptoms, (p= 0.005) and data delaying onset of symptoms (p = 0.006), progression of symptoms, (p= 0.005) and day 
of death (p =0.007). The most potent antioxidant activity was given by E. abyssinica, G. 
buchananii and C. decapetala, giving sample concentration reducing DPPH by 50% 
(Rsa50) of 20, 10 and 50µg/mL respectively. Major phytochemical groups detected in 
the selected plants were Alkaloids in S. pinata, terpenoids in E. abyssinica, flavonoids 
and phenols in G. buchananii. Results show that there is scientific basis for use of 
many plants in Hamuyundi and Mukhwa communities in Western Kenya. Further 
investigation is required to isolate and characterize compounds responsible for activity
found in G. buchananii and C. decapetala